[{"@context":"https:\/\/schema.org\/","@type":"BlogPosting","@id":"https:\/\/www.regionalcancercare.org\/news\/metastatic-prostate-cancer-what-to-know\/#BlogPosting","mainEntityOfPage":"https:\/\/www.regionalcancercare.org\/news\/metastatic-prostate-cancer-what-to-know\/","headline":"What Happens When Prostate Cancer Spreads to Other Parts of the Body?","name":"What Happens When Prostate Cancer Spreads to Other Parts of the Body?","description":"What Happens When Prostate Cancer Spreads to Other Parts of the Body? November 19, 2026 Being diagnosed with metastatic prostate cancer can be intimidating. Many patients have questions about their treatment options, symptom management, and what the future will hold. By educating themselves on the subject, patients can be empowered to make the decisions that [&hellip;]","datePublished":"2026-11-19","dateModified":"2026-11-19","author":{"@type":"Person","@id":"https:\/\/www.regionalcancercare.org\/news\/author\/seo-user\/#Person","name":"Advance SEO","url":"https:\/\/www.regionalcancercare.org\/news\/author\/seo-user\/","identifier":7,"image":{"@type":"ImageObject","@id":"https:\/\/secure.gravatar.com\/avatar\/25d521bea98e4070937950c92cd06d2b99615947d3d29e3682593c48f0372431?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/25d521bea98e4070937950c92cd06d2b99615947d3d29e3682593c48f0372431?s=96&d=mm&r=g","height":96,"width":96}},"publisher":{"@type":"Organization","name":"Regional Cancer Care Associates","logo":{"@type":"ImageObject","@id":"https:\/\/www.regionalcancercare.org\/wp-content\/uploads\/2021\/08\/logo.svg","url":"https:\/\/www.regionalcancercare.org\/wp-content\/uploads\/2021\/08\/logo.svg","width":506,"height":228}},"image":{"@type":"ImageObject","@id":"https:\/\/www.regionalcancercare.org\/wp-content\/uploads\/2026\/11\/urologist-using-model-to-explain-prostate-cancer-to-patient.jpg","url":"https:\/\/www.regionalcancercare.org\/wp-content\/uploads\/2026\/11\/urologist-using-model-to-explain-prostate-cancer-to-patient.jpg","height":679,"width":900},"url":"https:\/\/www.regionalcancercare.org\/news\/metastatic-prostate-cancer-what-to-know\/","about":["All Cancers"],"wordCount":2320,"articleBody":"\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\tWhat Happens When Prostate Cancer Spreads to Other Parts of the Body?\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\tNovember 19, 2026\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\tBeing diagnosed with metastatic prostate cancer can be intimidating. Many patients have questions about their treatment options, symptom management, and what the future will hold. By educating themselves on the subject, patients can be empowered to make the decisions that are best for them.Regional Cancer Care Associates (RCCA) is a network of more than 90 medical oncologists and hematologists who treat patients who have solid tumors, blood-based cancers, and benign blood disorders at more than 20 locations near you throughout New Jersey, Connecticut, and Massachusetts. Here, we help patients prepare for treatment with an overview of what to expect from metastatic prostate cancer and its care, including symptoms, monitoring, and treatment options.\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\tKey TakeawaysMetastatic prostate cancer is cancer that started in the prostate and spread to other parts of the body. It may be identified when a patient is first diagnosed as having prostate cancer or develop with recurrence of previously treated disease.Symptoms of metastatic prostate cancer depend on where the cancer spreads, and may include bone pain, neurological changes, urination problems, and swelling of the lymph nodes.Metastatic prostate cancer is identified and monitored using PSMA PET scans, bone scans, ctDNA liquid biopsies, and genetic biomarker testing.Treatment options may include androgen deprivation therapy, androgen pathway receptor inhibitor therapy, chemotherapy, targeted therapy, immunotherapy, combined treatments, and clinical trials.What Is Metastatic Prostate Cancer?Metastatic prostate cancer is cancer that starts in the prostate and spreads to other parts of the body. Cancer occurs when cells develop a DNA mutation that makes them reproduce rapidly, creating an abnormal tissue mass called a tumor. Tumor cells do not stick together well, and individual cells may break off the mass to be carried away in the bloodstream. If these cells reattach elsewhere in the body, they may continue to grow and form a new tumor. This process is called metastasis. Common sites of metastasis in prostate cancer include:Bones, especially the spine, pelvis, or ribsLymph nodesLiverLungsRarely, the brainOnce cancer has spread beyond its point of origin, it becomes very difficult to treat. Metastatic prostate cancer is considered incurable, and it has the lowest survival rate of all stages of prostate cancers. However, modern treatments help many patients live for years with a good quality of life.De Novo vs. Recurrent CancerSome patients have metastatic cancer at the time of their diagnosis. This is called de novo metastatic prostate cancer. Other patients have metastases as a recurrence of previously treated prostate cancer. Many years after treatment for localized prostate cancer, cells that were not eradicated by the original treatment may form into a new tumor or multiple tumors elsewhere in the body.Castration-Sensitive vs. Castration-Resistant Prostate CancerMost prostate cancers rely on testosterone to grow. Hormone therapy is often used to reduce testosterone levels in the body, starving the cancer of this &ldquo;fuel.&rdquo; Cancers that respond well to this treatment are called castration-sensitive cancers. Reference to &ldquo;castration&rdquo; can be disturbing, but in this context the term refers to significantly lowering testosterone by means of medical therapy. Over time, some cancers find ways to survive without natural testosterone. These cancers are castration-resistant, meaning that they continue to progress despite testosterone being reduced to very low &ndash; or &ldquo;castrate&rdquo; &#8212; &nbsp;levels.Symptoms of Metastatic Prostate CancerThe symptoms of metastatic cancer depend on where the cancer has spread. Some patients notice no changes at all. Others experience sexual dysfunction that is typical of earlier-stage prostate cancers, in addition to new issues caused by metastasis.BonesThe bones are the most common location for prostate cancer to spread. The cancer may move into the spine, pelvis, ribs, or skull, causing symptoms such as:Dull or stabbing bone painWeak bones that are vulnerable to fractureNumbness or tingling in the legsLoss of bowel or bladder controlNumbness, tingling, and incontinence are signs of spinal cord compression, meaning that a metastatic tumor is pressing against the spinal cord. This is an emergency. Patients who experience symptoms of spinal cord compression should obtain prompt medical attention to prevent permanent damage.Lymph NodesLymph nodes are tiny organs that filter body fluids to prevent infection. There are many lymph nodes near the prostate, making them another common site for metastasis. Cancer cells in the lymph nodes can block the lymphatic system, stopping fluid from draining. Lymph fluid accumulates in the legs, causing heaviness and swelling known as lymphedema.Bladder and UrethraThe prostate surrounds the urethra and is directly adjacent to the bladder. Large tumors can press against these structures or spread into them, impeding their function. Symptoms may include:Frequent urination, especially at nightDifficulty urinatingFeeling an urge to urinate when the bladder is emptyBlood in urine or semenLiver and LungsThe liver and lungs are also common places for prostate cancer to spread. Blood passes through the liver for filtering and the lungs for oxygen transfer, so traveling cancer cells can easily reach these organs. Symptoms of liver metastases include:Pain on the right side of the abdomenSwollen abdomenYellowing of the skinItchy skinMetastases in the lungs, meanwhile, may cause:Shortness of breathPersistent coughsCoughing up bloodSystemicCancer in any location takes a toll on the body. Prostate cancer requires enormous amounts of energy to spread, and it steals this energy from the rest of the body. Patients with metastatic prostate cancer often experience persistent exhaustion, fatigue, and unexplained weight loss, as their metabolisms begin to feed the cancer instead of keeping the body fueled.How Is Metastatic Prostate Cancer Monitored?Prostate-specific antigen (PSA) blood tests are the most common screening method for early-stage prostate cancer. PSA testing remains an important tool for monitoring metastatic prostate cancer, although PSA levels do not always reflect the full extent or activity of the disease.Oncologists may also use imaging such as a PSMA PET scan to locate prostate cancer that has spread or recurred. PSMA stands for prostate-specific membrane antigen, which is a protein that is often found on the surface of prostate cancer cells. The test uses a radioactive tracer that travels through the blood and attaches to PSMA proteins. Physicians then perform a PET (positron emission tomography) scan. Cells that were located by the tracer are highlighted on the scan results, showing oncologists where the cancer has spread.Other Tests for Metastatic Prostate CancerWhile PSMA PET scans are highly sensitive for detecting and staging prostate cancer, other tests may also be used to locate metastases and evaluate the status of patient&rsquo;s prostate cancer. These include:Bone scans: These imaging tests use a small amount of radioactive tracer to locate abnormal tissue masses, unusual cell activity, and hidden fractures in the bones.Liquid biopsy: This laboratory test examines a blood sample for fragments of circulating tumor DNA (ctDNA). Fluctuating ctDNA levels can indicate whether treatments are effective.Biomarker testing: Genetic tests look for specific gene mutations in cancer cells, which may indicate that the cancer for will respond to certain targeted therapies..These tests are used to guide treatment plans by helping oncologists predict how the cancer will respond to specific therapies. Every cancer is unique, so getting more information is key to developing a treatment plan.Treatment Options for Metastatic Prostate CancerRCCA oncologists develop personalized treatment plans for every patient they see. The most effective therapies depend on several factors, including whether the cancer is castration-sensitive and whether it features certain biomarkers. Treatment options may include:Androgen Deprivation TherapyAndrogen deprivation therapy (ADT) is the first-line treatment for castration-sensitive metastatic prostate cancer. ADT is a type of hormone therapy that reduces testosterone to castration levels, starving the cancer of what it needs to grow and spread.ADT is often administered alongside another drug. These include androgen receptor pathway inhibitors and chemotherapy, among others.When ADT Stops WorkingWhen ADT and agents given in combination with it stop working, oncologists pivot to new treatments. Recent innovations have led to significant improvements in patient survival and quality of life for metastatic castration-resistant prostate cancer. Options at this stage include:PARP inhibitors: This targeted therapy blocks enzymes that cancer cells use to repair damaged DNA, causing a breakdown in cells that already have a faulty DNA-repair gene.Sipuleucel-T: This immunotherapy modifies the patient&rsquo;s own white blood cells to attack cancer cells, empowering the immune system to fight cancer.Pembrolizumab: This immunotherapy blocks the PD-1 protein, which some cancer cells use to turn off the immune response. This allows the immune system to find and attack cancer cells.Lutetium-177 PSMA: This targeted therapy uses a radioactive particle that attaches to PSMA proteins, delivering radiation directly to cancer cells.Radium-223: This targeted therapy drug mimics calcium, traveling to areas of rapid bone growth. It is used to treat prostate cancer that has spread into the bones.RCCA also provides patients access to clinical trials, which are used to test emerging therapies. Patients who qualify for clinical trials may gain access to investigational treatments before they become widely available.Learn More about Metastatic Prostate Cancer Care Near You in NJ, CT, and MAMetastatic prostate cancer is an intimidating diagnosis, but with modern treatments, many patients can preserve their quality of life for years. Regional Cancer Care Associates (RCCA) provides cutting-edge therapies and clinical trials at more than 20 locations near you in New Jersey, Connecticut, and Massachusetts. Contact RCCA today to learn more about prostate cancer care options close to home or to request an appointment with a board-certified oncologist..Frequently Asked Questions About Metastatic Prostate CancerWhat are the symptoms of metastatic prostate cancer?The symptoms of metastatic cancer depend on where the cancer has spread. General symptoms include extreme tiredness, appetite loss, and unexplained weight loss. Site-specific symptoms include bone pain, numbness or tingling in the extremities, bowel or bladder incontinence, and fluid buildup in the legs.Where does prostate cancer typically spread to first?The bones are the most common site of distant spread for prostate cancer. The cancer may move into the spine, pelvis, ribs, or skull. Other common sites for metastasis include the lymph nodes, liver, and lungs.Is metastatic prostate cancer curable?Metastatic prostate cancer is generally considered incurable, but treatment can often control the disease for extended periods. Metastatic prostate cancer often can be controlled for years, allowing patients to extend their survival while maintaining a high quality of life.What is the survival rate for Stage 4 prostate cancer?The 5-year survival rate for stage 4 prostate cancer is about 38%, meaning that about 38% of patients diagnosed with stage 4 prostate cancer survive for five years. This number is a statistical average and should not be taken as a prediction of any individual&rsquo;s survival. A specific patient&rsquo;s prognosis depends on a variety of factors, including how far the cancer has spread, the locations of metastases, the patient&rsquo;s overall health, and access to recent therapies.What does castration-resistant prostate cancer mean?Castration-resistant prostate cancer is prostate cancer that continues to spread when testosterone levels are very low. Most early-stage prostate cancers rely on testosterone to grow, making hormone therapy an effective mode of treatment. Over time, however, some cancers adapt by producing their own testosterone or growing without it, making them resistant to hormone treatments.Should I get a second opinion if diagnosed with metastatic prostate cancer?Yes, you should always obtain a second opinion for serious diagnoses, including metastatic prostate cancer. A second opinion can confirm the diagnosis, provide new information, or create opportunities to explore different treatments that may be more effective at controlling the cancer.What genetic tests should I get if I have advanced prostate cancer?If you have advanced prostate cancer, you may want to obtain a germline genetic test. This test looks for inherited gene mutations that are known to cause cancer. The results may qualify you for targeted therapies such as PARP inhibitors, and they can indicate that your children and close relatives might also be at risk of elevated risk of developing cancer. You may also want to obtain somatic testing, which analyzes DNA changes inside cancer cells to predict how the tumor will respond to certain therapies.How long can you live with metastatic prostate cancer?Survival with metastatic prostate cancer varies widely. Some patients live for many years with modern treatment, while others have more aggressive disease that doesn&rsquo;t respond well to therapy. Prognosis depends on factors such as the extent and location of spread, response to treatment, cancer biology, and overall health.\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\twe are here for you\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\tFor more information or to schedule an appointment, call 844-346-7222. You can also schedule an appointment by calling the\u00a0RCCA location\u00a0nearest you.\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\trequest an appointment\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\tRELATED ARTICLES\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\tI Was Just Diagnosed with Colon Cancer. What Are the Next Steps?\t\t\t\t\t\t\t\t\t\t\t\tA colon cancer diagnosis is usually confirmed with a biopsy taken during an exam of the colon. This exam often follows abnormal colon cancer screening\t\t\t\t\t\t\t\t\tLearn More\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\tWhere Can You Find Expert Cancer Care Near You in Toms River and Ocean County, NJ?\t\t\t\t\t\t\t\t\t\t\t\tTransportation is an underestimated burden of cancer care. When visiting the oncologist once or twice each week for chemotherapy, the travel time adds up. A\t\t\t\t\t\t\t\t\tLearn More\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\tRCCA Founder Andrew Pecora, MD, Pioneers Treatment Regimen That Cuts 5-Year Risk of Advanced Melanoma Recurrence in Half\t\t\t\t\t\t\t\t\t\t\t\t\u201cUnfortunately, your cancer has returned.\u201d It\u2019s news that anyone who has been treated for the disease dreads hearing. And it\u2019s news that far fewer people\t\t\t\t\t\t\t\t\tLearn More\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\tRegional Cancer Care Associates is one of fewer than 200 medical practices in the country selected to participate in the Oncology Care Model (OCM); a recent Medicare initiative aimed at improving care coordination and access to and quality of care for Medicare beneficiaries undergoing chemotherapy treatment.\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t"},{"@context":"https:\/\/schema.org\/","@type":"BreadcrumbList","itemListElement":[{"@type":"ListItem","position":1,"name":"News","item":"https:\/\/www.regionalcancercare.org\/news\/#breadcrumbitem"},{"@type":"ListItem","position":2,"name":"What Happens When Prostate Cancer Spreads to Other Parts of the Body?","item":"https:\/\/www.regionalcancercare.org\/news\/metastatic-prostate-cancer-what-to-know\/#breadcrumbitem"}]}]